Eyster M E, Diamondstone L S, Lien J M, Ehmann W C, Quan S, Goedert J J
Department of Medicine, Pennsylvania State School of Medicine, Hershey.
J Acquir Immune Defic Syndr (1988). 1993 Jun;6(6):602-10.
The objective of this prospective cohort study was to describe the natural history of hepatitis C virus (HCV) infection and the effect of human immunodeficiency virus (HIV) on the clinical manifestations of HCV liver disease. Two hundred twenty-three hemophiliacs were followed in a comprehensive care setting with periodic clinical and laboratory evaluations. Dates of HIV seroconversion were determined retrospectively from frozen sera. HCV assays were performed by a "second generation" four-antigen recombinant immunoblot assay (RIBA 2). Liver failure was found after a latency period of 10 to 20 years in 9% of multitransfused HCV-positive/HIV-positive adult hemophiliacs without an AIDS-defining opportunistic infection or malignancy. Lymphocytopenia, decreased CD4 counts, and, possibly, thrombocytopenia were associated with liver failure which appeared to be accelerated by HIV disease and its treatment. This form of severe liver disease is being seen with increasing frequency among multi-transfused persons with hemophilia who are coinfected with HCV and HIV.
这项前瞻性队列研究的目的是描述丙型肝炎病毒(HCV)感染的自然病程以及人类免疫缺陷病毒(HIV)对HCV肝病临床表现的影响。在一个综合护理环境中对223名血友病患者进行随访,并定期进行临床和实验室评估。HIV血清转化日期通过回顾性分析冷冻血清来确定。HCV检测采用“第二代”四抗原重组免疫印迹法(RIBA 2)。在没有艾滋病定义的机会性感染或恶性肿瘤的多次输血的HCV阳性/HIV阳性成年血友病患者中,9%的患者在10至20年的潜伏期后出现肝功能衰竭。淋巴细胞减少、CD4计数降低以及可能的血小板减少与肝功能衰竭有关,而HIV疾病及其治疗似乎会加速肝功能衰竭。这种严重肝病形式在同时感染HCV和HIV的多次输血血友病患者中出现的频率越来越高。